Abstract The effects of electrophoretically applied prostaglandin D2 (PGD2) on neuronal activity in the rat lateral preoptic area (LPOA) and posterior hypothalamic area (PHA) were examined. In the LPOA, 20% of the tested neurons were excited, 26% inhibited, and 6% showed bidirectional response. The direct effects often showed desensitization after repeated applications. Neurons excited by PGD2 were significantly sensitive (excitation) to acetylcholine (ACh). The ACh excitatory effect was sometimes (38%) attenuated, blocked, or reversed by concurrent PGD2 application. Excitatory or inhibitory effect of noradrenaline (NA) was not related to the effects of PGD2, however, modulation of the NA responses by PGD2 was common (58%). Inhibition, the predominant NA response, was changed to no effect or to excitation during simultaneous PGD2 application. Changes of the NA responses from inhibition to excitation, or from excitation to inhibition-excitation sequences were observed after PGD2 infusion into the third cerebral ventricle at low concentrations. In 43% of the cells, neurotransmission in the LPOA following ventral noradrenergic bundle stimulation was modified by PGD2 application. PGD2 application tended to reduce the duration of inhibition and to extend that of excitation. The direct effects of PGD2 in the PHA were similar to those in the LPOA. Desensitization was also observed in the PHA, but no interrelations were observed among the effects of PGD2, ACh, and NA. Modulation of ACh and NA responses by PGD2 was rarely seen in the PHA. Possible contributions of PGD2 to sleep and thermoregulation are discussed.
hypothalamus, and olfactory bulb (NARUMIYA et al., 1982) . High concentrations of PGD synthetase, PGD2 dehydrogenase and binding proteins specific for PGD2 are present in the hypothalamus (SHIMIzu et a!., 1979a (SHIMIzu et a!., , b, 1982 T0KUM0T0 et al., 1982; YAMASHITA et al., 1983) . Since these enzymes and binding proteins are very rich in neural elements (SHIMIZU et al., 1979a) , PGD2 has been considered to be a neurotransmitter or neuromodulator and to have a physiological role in the CNS. In recent years, the effects of PGD2 in the CNS have been greatly elucidated, and it has been reported that administration of PGD2 into the CNS produces hypothermia (UENO et al., 1982a) , an increment of sleep (UENO et al., 1982b (UENO et al., , 1983 , and suppression of luteinizing hormone release (KINOsHITA et al., 1982) .
The preoptic area (POA) in the hypothalamus is deeply involved in central regulatory control of sleep. Stimulation of this area produces cortical EEG synchronization and leads to sleep (CLEMENTE and STERMAN, 1967) . On the other hand, the suppression of sleep by POA lesion has been observed in the rat (NAUTA, 1946) and cat (MCGINTY and STERMAN, 1968) . Recent investigation using a multiple unit recording technique revealed increased neuronal activity in the POA preceding the shift from the waking state to slow-wave sleep (HANADA and KAWAMURA,1984) . The posterior hypothalamic area (PHA) is also linked to the regulation of sleep. High frequency stimulation of this area induces persistent EEG desynchronization in cerveau isole cats (BELARDETTI et al., 1977) , and lesions disturb the awakening of rats (NAUTA, 1946) . We have examined the direct effects of PGD2 on hypothalamic neurons, and its effects on responses to several neurotransmitters by microelectrophoresis to elucidate the possible contributions of PGD2 to the physiological process of sleep.
MATERIALS AND METHODS
Twenty two male Wistar rats weighing 200-350 g were used. The rats were anesthetized with urethane (1.4 g/kg, i.p.). Subsequent maintenance doses were injected as necessary. Rectal temperature was maintained at 37 ± 0.5°C by a heating blanket. The head was secured in a stereotaxic frame and a portion of the calvarium over the hypothalamus in the right hemisphere was removed. The meninges were removed and the exposed brain tissue was covered with 1 % agar in physiological saline. A concentric bipolar stimulating electrode (outer diameter, 0.5 mm; inner diameter, 0.2 mm; polar distance 0.2-0.4 mm) was placed in the ventral noradrenergic (V-NA) bundle at A, 1.0; L, 1.5; H, -1.7 (6.7 from the brain surface). All stereotaxic coordinates are in mm, according to the atlas of KoNIG and KLIPPEL (1963) . Stimulation pulses were 0.2-0.3 ms in duration and up to 0.6 mA in intensity. Single neuron discharges were recorded from the lateral POA (LPOA) (A, 6.6±0.3; L, 1.6±0.2; H, -2.3±0.7) and the PHA (A, 3.8±0.3; L, 1.3±0.3; H, -2 .7 + 0.7). Seven-barrelled glass micropipettes (overall tip diameter, approximately 1,um) were glued to single extracellular recording electrodes filled with 0.5 M sodium acetate plus 2% pontamine sky blue (DC resistance, 10-15 Me). The electrode tip extended about 30 µm beyond the pipette tip. Each capillary of the seven-barrelled pipette was filled with one of the following solutions: 1.0 M acetylcholine Cl (ACh, pH 4.5); 0.5 M noradrenaline HCl (NA, in 2% ascorbic acid, pH 3.5); 0.5 M dopamine HCl (DA, in 2% ascorbic acid, pH 3.5); 0.3 M PGD2 (pH 7.5); and 0.2 M NaCI (pH 6.0). Each pipettes DC resistance was 50-100 MSS. One barrel, used as a current balancing channel, was filled with 0.5 M NaCI. The effects of these chemicals were assessed on neurons that showed spontaneous activity. Specific chemical effects were distinguished from current effects by criteria described elsewhere (OoMURA et al., 1969) .
The modulatory effect of PGD2 was determined by comparing responses to NA or ACh, applied at the same current intensity and duration, before and during PGD2 application. The ratio of the mean firing rate per s in the period of significant response to that of the base line was computed for each ratemeter histogram. A change of more than 50% of this ratio was considered significant. In addition to electrophoresis of PGD2, 7 rats were cannulated in the third cerebral ventricle, and PGD2 (50-150 nmol in 5 µl physiological saline) was infused during neuronal recording. These criteria were used to assess PGD2 effects in the LPOA and PHA.
The effects of PGD2 on LPOA response to V-NA bundle stimulation were analyzed similarly. Poststimulus time histograms (PSTHs) compiled from exactly the same number of stimulations were compared before and during PGD2 application. The ratio of the mean height of the bins in the period of significant response to that of the base line was calculated for each PSTH. A change of more than 25% in this ratio was considered to be significant.
In each instance, when extracellular recording and electrophoretic testing were completed, pontamine sky blue was injected electrophoretically into the recording site for subsequent histological examination. After each experiment, the rat was perfused via the left cardiac ventricle with 10% neutral formalin solution. The brain was removed, blocked and prepared for frozen sectioning into 50 µm sections. Sections were stained with neutral red, and recording sites were determined by the presence of pontamine sky blue stain.
Statistical calculations were done by the Fisher exact probability test. Only values of p <0.05 were considered to be significant.
RESULTS

Effects of PGD2 on LPOA neurons
Direct effects of PGD2. The application of PGD2 to neurons in the LPOA produced excitation in about 20% (21/105), inhibition in 26% (26/105), and bidirectional responses in about 6% (6/105). Activity of the remaining 52 neurons did not change. Both the excitatory and inhibitory effects of PGD2, as shown in Fig.  lA and B respectively, showed desensitization, or tachyphylaxis upon repeated application of .PGD2. This was observed in about 23% of the neurons (24/105). The interrelations between the effects of PGD2 and ACh on 50 neurons were examined, and those of PGD2 and NA on 65 neurons were examined. As shown in Table 1 , 58 and 10% of the neurons were excited and inhibited, respectively, by ACh. These respective ratios for NA were 20 and 68% ( Table 1 ). Neurons that were excited by PGD2 were significantly excited by ACh (p <0.05, Fisher's test), but there was no similar interrelation between the effects of PGD2 and the effects of NA. Modulatory effects of PGD2. The ACh and NA effects on LPOA neurons were significantly modulated by PGD2. The excitatory effects of ACh were modified in 38% of 21 neurons tested; 7 were suppressed and 1 was reversed to inhibition (Table  2) . PGD2 modified the original NA responses of 58% of 38 neurons tested. The main modification was a change from inhibition to no effect or to excitation (68%,19 of 28 neurons). The neuron whose activity is shown in Fig. 2 was excited by ACh, and inhibited by NA. Figure 2 , upper, shows that PGD2, itself, had no effect at -50 to -140 nA; but PGD2 application at -140 nA almost blocked the excitatory effect Japanese Journal of Physiology , and 90 nA. NA inhibition at 40 nA, no effect at 20 nA. PGD2 no effect at -50 and -140 nA. Middle: during PGD2 application at -140 nA; ACh no effect at 90 nA, slight excitation and late inhibition at 140 nA; NA, no effect at 40 nA. Within 1 min after termination of PGD2; ACh excitation, but attenuated at 140 nA; NA, slight excitation or no effect at 40 nA; approximately 3 min after, ACh excitation and near recovery at 90 nA. Lower: 20 min after; NA no effect at 70,110, and 70 nA; 27 min after, slight inhibition at 90 nA. Ordinate, impulses/s.
of ACh at 90 nA, and completely blocked the inhibitory effect of NA at 40 nA (Fig.  2, middle) . After terminating the PGD2 application, the excitatory effect of ACh returned quickly within 3 min, but the block of the NA inhibitory effect was long-lasting ( Fig. 2, lower) and the inhibition did not reappear until about 27 min after termination of the PGD2 application. Modulation of the NA response lasted more than 5 min after termination of PGD2 application in three neurons. The neuron whose activity is shown in Fig. 3 was inhibited by DA and NA applications (Fig. 3, upper) . Continuous PGD2 application at -280 nA gradually increased the firing rate (not shown in figure) . Seven min after the start of PGD2 application, the effects of NA at 40 nA were totally blocked and NA application at 50 nA produced slight inhibition followed by much more rapid recovery than that in the absence of PGD2, and possibly some excitation (Fig. 3, lower) . About 4 min after termination of the PGD2 application, this neuron was again remarkably inhibited by NA application at 30 nA (Fig. 3, lower) . The inhibitory effect of DA on this neuron was also suppressed by PGD2. In this paper the detailed analysis on the DA effect was not carried out. The effects of PGD2 application on both ACh and NA responses were examined on 20 neurons; ACh responses were modified in 6 and NA responses in 13.
Modulation by PGD2 infused into the third cerebral ventricle. The effects on NA responses were examined in 5 LPOA neurons. The neuron whose activity is Japanese Journal of Physiology inhibition at 40 and 50 nA (slight at 30 nA); Nat, no effect at 40 nA. DA, inhibition at 20 nA. Lower: during PGD2 application at -280 nA, NA, no effect at 40 nA and excitation preceded by slight inhibition at 50 nA; DA, no effect at 40 nA. PGD2 application, started 7 min before beginning of the lower trace, increased firing rate gradually. Approximately 4 min after termination of PGD2; NA at 30 nA remarkably inhibited. Two min after; DA attenuated inhibition at 20 nA. Ordinate, impulses/s. Dz ON HYPOTHALAMIC NEURON 503 shown in Fig. 4 was inhibited by NA and excited by ACh. The NA response was still inhibitory two and 4 min after infusion, but it changed to excitation at 13 min. It again returned to inhibition after 23 min. The response to ACh on this neuron was not changed by PGD2 infusion. Two of three neurons that were inhibited by electrophoretically applied NA were excited by NA about 15 min after infusion of PGD2. Modulation of synaptic transmission by PGD2. The effects of PGD2 on the responses to stimulation of the V-NA bundle, a major noradrenergic input to the hypothalamus, were tested on 14 LPOA neurons. In the neuron whose activity is shown in Fig. 5 , stimulation of the V-NA bundle produced inhibition (onset latency 13 ms, duration 73 ms) followed by excitation (duration 20 ms) (Fig. 5A ). This neuron was inhibited by electrophoretic application of NA (Fig. 5a ). During PGD2 application at -90 nA, the inhibition was attenuated (onset latency 19 ms, duration 51 ms) but the duration of excitation was unchanged (Fig. SB) , and the NA response was changed to excitation (Fig. Sb) . The onset latency of the inhibition became remarkably prolonged. One of the reasons was probably due to the change from the inhibition to the excitation of the NA effect. During PGD2 application at -280 nA, the duration of inhibition, i.e. complete suppression of firing, was only 11 ms, that Vol. 36, No. 3, 1986 control, NA no effect at 15 nA; inhibition followed by excitation at 30 nA; inhibition at 30 and 50 nA. b: during PGD2 at -90 nA. Note change of NA effect to excitation at 30 and 50 nA. c: during PGD2 at -280 nA, NA slight inhibition followed by excitation at 15 nA; excitation at 10 nA. Note remarkable excitation at low NA application current. d: recovery of NA inhibitory effect. Four min after termination of PGD2, NA inhibition at 30 nA; inhibition followed by excitation at 70 nA; inhibition at 50 and 40 nA.
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of excitation was not clear (Fig. 5C) , and the excitatory effect of NA became more pronounced at low doses of 15 and 10 nA (Fig. Sc) . Two min after termination of the PGD2 application, the extent of the inhibition (onset latency 14 ms, duration 56 ms) did not recover completely to the control level but the onset of excitation was almost the same as that of A (Fig. SD) . The NA response also changed back to inhibition (Fig. Sd) . PSTHs of 6 neurons (43%, 6/14) were modified by electrophoretically applied PGD2. Electrophoretically applied NA responses were examined on four neurons and the NA responses were blocked or reversed in all of them (29%, 4/14). The duration of excitation of five neurons that had excitatory and inhibitory components-either excitatory-inhibitory or inhibitory-excitatoryincreased, and the duration of the inhibition diminished. The excitatory component of one neuron disappeared.
Effects of PGD2 on PHA neurons
The effects of PGD2 on 32 neurons in the PHA were similar to those in the LPOA;16% of the tested neurons were excited, 25% were inhibited and 9% showed bidirectional responses. The remaining 50% of the neurons showed no marked response. Three neurons were desensitized. There was no relation between the effects of PGD2 and those of ACh or NA. There was no modulation of 17 ACh responses by concurrent application of PGD2. Modulation occurred for only two of 19 NA responding neurons-one from excitation to no effect, the other from excitation to inhibition.
The modulation of NA and ACh effects by PGD2 was significant on the LPOA neurons compared to that of the PHA neurons (Fisher's test, p <0.01).
DISCUSSION
During the last decade, the effects of PGE and PGF in the CNS have been investigated in great detail. Direct effects on neuronal activity in the hypothalamus were mainly excitatory and the incidence of responsive neurons ranged from 9 to 83% (JELL and SWEATMAN, 1977; POULAIN and CARETTE, 1974; STIT and HARDY, 1975) . In contrast, the effects of PGD2 on the CNS have received less attention. This is the first report of the effects of PGD2 on CNS neurons. Almost half of the neurons tested in the LPOA and PHA responded. Excitatory and inhibitory effects were observed to be almost equal. In 6%, bidirectional responses also occurred that were similar to cerebellar Purkinje neuron responses to PGF applications (SIGGINs et al., 1971) .
In the cat, the effects of PGE and PGF on brain stem neurons (AvANZINO et al., 1966) frequently showed desensitization but this was rarely seen in the hypothalamus (JELL and SWEATMAN, 1977) . In the guinea pig, however, desensitization of. hypothalamic neurons often occurred (PoULAIN and CARETTE, 1974) . In the rat, only a few neurons in the cerebellar cortex, reticular formation, hippocampus and cerebral cortex were desensitized after repeated applications of PGE1 (SIGGINs et al., 1971) . As shown in the present experiment, PGD2 responses were desensitized in one fourth to one fifth of the rat hypothalamic neurons. External application of PGD2 to neuroblastoma x glioma hybrid cells produced long-lasting depolarization preceded by transient membrane hyperpolarization, and in almost all cases this effect showed desensitization (HIGASHIDA et al., 1984) . It is suspected that desensitization is a general characteristic of the PGs but that the rate of occurrence depends on the species and the sites examined.
Antagonism of the NA response of cerebellar Purkinje neurons by PGE has been reported (SIGGINS et al., 1971) , but no such effect has been observed on hypothalamic neurons (STIT and HARDY, 1975; JELL and SWEATMAN, 1977) . The present experiments revealed modulation by PGD2 of both the NA response and the ACh responses of LPOA neurons. This modulation of NA responses seemed to be of two types-long-acting (Fig. 2) and short-acting (Figs. 3 and 5) . A difference in sensitivity to PGD2 or a different modulatory mechanism may account for the two types.
The highly variable direct effect of PGD2 on spontaneous activity of LPOA neurons and its potent modulation of catecholamine and ACh responses suggest that PGD2 could act as a neuromodulator rather than as a neurotransmitter. Moreover, neurotransmission in the LPOA following V-NA bundle stimulation was modulated by PGD2 in 43% of the neurons tested. At the same time, the direct NA effects on the same neurons were also modulated by PGD2 (Fig. 5) . Recently, PGD2 effects on sympathetic neurotransmission were reported in the anococcygeus muscle (BEDWANI and HILL, 1980) and the nictitating membrane (HEMKER and AIKEN, 1980) . Facilitation of transmission occurred in the former, and inhibition in the latter. These findings may support the modulatory role of PGD2 on neurotransmission in the CNS.
The POA and PHA have significant roles in the regulation of both the sleepwaking cycle and body temperature. Since an increment of sleep, and hypothermia are both elicited by microinjection of PGD2 into the POA and not by injection into the PHA (UENO et al., 1982a, b) , the POA is a site of action of PGD2. Microinjection of the other sleep-inducing peptide into the POA also induces excess slow-wave sleep (GARCIA-ARRARAS and PAPPENHEIMER, 1983) . In the present• experiment, PGD2 had almost no modulatory effect on PHA neuron responses to NA or ACh. Microinjection of NA into the POA (HERNANDEZ-PEON et al., 1963; LoMAx et al., 1969; BECKMAN, 1970) or cerebral ventricle (CoRDEAU et al., 1971; GEYER et al., 1972) produced alertness and hyperthermia, while microinjection of ACh into the POA elicited sleep (HERNANDEZ-PEON et al., 1963) and hypothermia (BECKMAN and CARLISLE, 1969; LoMAx et al., 1969) . Moreover, it has been reported that NA suppresses the activity of warm-sensitive neurons and facilitates that of cold-sensitive neurons in the rat (MURAKAMI, 1973) and rabbit (HORI and NAKAYAMA, 1973) POA. The modulatory effects of NA and ACh observed in the present experiment might contribute to the PGD2 hypnogenic and hypothermal actions. This modulation also occurred in the experiment in which PGD2 was infused into the third cerebral ventricle (Fig. 4) ; PGD2 was infused at doses of 50 to 150 nmol. When we estimated the volume of the rat cerebrospinal fluid as 300 µl (SHIMIzu et al., 1984) , the PGD2 concentration was 167-500' µM. When a certain peptide was injected into the cerebral ventricle, the brain parenchymal concentration became 1 % of the injected dose 20 min after injection (DE WILDT et al., 1982) . If we assume the same diffusion rate, although granting that the substances were different, the concentration of PGD2 in this infusion experiment was 1.7 to 5 µM and might be comparable to that in the behavioral experiment in which PGD2 induced excess sleep. The fact that PGD2 significantly excited neurons that were excited by ACh (Table 1 ) might also contribute to the increment of sleep and hypothermia produced by PGD2 alone, judging from the ACh microinjection data. It seems reasonable to conclude that PGD2 is a neuromodulator and probably modulates neurotransmission in the POA. Through this mechanism, PGD2 could be important to sleep-waking as well as to body temperature regulation.
